Tło Oladoctor

Palgesic retard 50 mg comprimidos de liberaciÓn prolongada efg

About the medicine

Jak stosować Palgesic retard 50 mg comprimidos de liberaciÓn prolongada efg

Introduction

Package Leaflet: Information for the User

Palgesic retard 25 mg prolonged-release tablets EFG

Palgesic retard 50 mg prolonged-release tablets EFG

Palgesic retard 100 mg prolonged-release tabletsEFG

Palgesic retard 150 mg prolonged-release tablets EFG

Palgesic retard 200 mg prolonged-release tablets EFG

Palgesic retard 250 mg prolonged-release tablets EFG

tapentadol

Read this package leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others even if they have the same symptoms as you, as it may harm them.
  • If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this package leaflet. See section 4.

1. What is Palgesic retard and what is it used for

Tapentadol - the active ingredient in Palgesic retard - is a potent analgesic that belongs to the class of opioids.

Tapentadol is used for the treatment of severe chronic pain in adults, which can only be adequately treated with an opioid analgesic.

2. What you need to know before starting to take Palgesic retard

Do not take Palgesic retard

  • If you are allergic to tapentadol or any of the other components of this medication (listed in section 6),
  • If you have asthma or if your breathing is slow or shallow to dangerous levels [respiratory depression; hypercapnia (concentration of carbon dioxide in blood above normal)],
  • If you have a disease in which the intestine does not function properly (intestinal paralysis),
  • If you have consumed alcohol, sleeping pills, other painkillers, or other psychoactive medications (medications that affect mood and emotions) at high doses (see section "Other medications and tapentadol").

Warnings and precautions

Consult your doctor or pharmacist before starting to take tapentadol:

  • If your breathing is slow or shallow,
  • If you have increased intracranial pressure or altered consciousness even to coma,
  • If you have had a head trauma or brain tumors,
  • If you have liver or kidney disease (see section “How to take Palgesic retard”),
  • If you have a pancreatic disease (such as pancreatitis) or biliary tract disease,
  • If you are taking medications called mixed opioid agonist/antagonists (e.g. pentazocine, nalbuphine) or partial agonists of the µ opioid receptors (e.g. buprenorphine),
  • If you are prone to epilepsy or seizures, or if you are taking other medications known to increase the risk of seizures, as the risk of seizures may increase,
  • If you or a family member has a history of alcohol abuse, prescription medication abuse, or illicit substance abuse (“addiction”),
  • If you smoke,
  • If you have ever had problems with your mood (depression, anxiety, or personality disorder) or have received treatment from a psychiatrist for other mental health conditions.

This medication contains tapentadol, which is an opioid medication. Repeated use of opioid analgesics may reduce the effectiveness of the medication (you may become accustomed to it). It may also lead to dependence and abuse, which may result in a potentially fatal overdose. It is essential to inform your doctor if you think you may have developed dependence on tapentadol. Your use (even at therapeutic doses) may cause physical dependence, which may lead to withdrawal symptoms and a recurrence of your problems if you stop taking this medication abruptly.

Tapentadol may cause physical and psychological addiction. If you have a tendency to abuse medications or have medication dependence, you should take these tablets only for short periods of time under strict medical supervision.

Respiratory disorders related to sleep

Tapentadol may cause respiratory disorders related to sleep such as sleep apnea (pauses in breathing during sleep) and sleep-related hypoxemia (low oxygen levels in the blood). Symptoms may include pauses in breathing during sleep, nocturnal awakenings due to difficulty breathing, difficulty maintaining sleep, or excessive daytime somnolence. If you or someone else observes these symptoms, consult your doctor. Your doctor may consider reducing the dose.

Other medications and tapentadol

Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.

The risk of side effects increases if you are taking medications that may cause seizures (e.g. certain antidepressants or antipsychotics). The risk of seizures increases if you take tapentadol simultaneously with these medications. Your doctor will tell you if tapentadol is suitable for you.

The concomitant use of tapentadol and sedatives such as benzodiazepines or related medications (certain sleeping pills or tranquilizers [e.g. barbiturates] or painkillers such as opioids, morphine, and codeine [also as a cough medication], antipsychotics, H1 antihistamines, alcohol) increases the risk of drowsiness, respiratory difficulties (respiratory depression), coma, and may be potentially fatal. Therefore, concomitant use should only be considered when other treatment options are not possible.

However, if your doctor prescribes tapentadol with sedatives, you should limit the dose and duration of concomitant treatment.

The concomitant use of opioids and medications used to treat epilepsy, nerve pain, or anxiety (gabapentin and pregabalin) increases the risk of opioid overdose, respiratory depression, and may be potentially fatal.

Inform your doctor if you are taking gabapentin or pregabalin or any other sedative, and follow your doctor's dosage recommendations exactly. It may be helpful to inform friends or family members about the symptoms mentioned above. Contact your doctor when you experience these symptoms.

If you are taking a type of medication that affects serotonin levels (e.g. certain medications for depression), speak with your doctor before taking tapentadol, as there have been cases of "serotonin syndrome". Serotonin syndrome is a rare but potentially fatal condition. Symptoms may include involuntary muscle contractions, including those that control eye movement, agitation, excessive sweating, tremors, exaggerated reflexes, increased muscle tension, and body temperature above 38°C. Your doctor may provide additional information.

The concomitant administration of tapentadol with other types of medications called mixed agonist/antagonist µ opioid receptor agonists (e.g. pentazocine, nalbuphine) or partial agonists of the µ opioid receptors (e.g. buprenorphine) has not been studied. Tapentadol may not have the same effectiveness if administered with one of these medications. Inform your doctor if you are currently being treated with one of these medications.

The administration of tapentadol with potent inhibitors or inducers (e.g. rifampicin, phenobarbital, St. John's Wort) of certain enzymes necessary for the elimination of tapentadol from the body may affect the efficacy of tapentadol or cause adverse effects, especially when starting or stopping this other type of medication. Inform your doctor about all the medications you are taking.

Tapentadol should not be taken with MAO inhibitors (medications for depression). Inform your doctor if you are taking MAO inhibitors or have taken them in the last 14 days.

Taking tapentadol with food, drinks, and alcohol

Do not consume alcohol while taking tapentadol, as some of its adverse effects, such as drowsiness, may increase. Food intake does not affect the effect of this medication.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medication.

Do not take this medication:

  • If you are pregnant, unless your doctor has indicated otherwise, as tapentadol may cause withdrawal symptoms in the newborn, which may put the newborn's life at risk if not detected and treated by a doctor,
  • During delivery, as it may cause slow or shallow breathing in the newborn,
  • During breastfeeding, as it may be excreted in breast milk.

Driving and operating machinery

Ask your doctor if you can drive or operate machinery during tapentadol treatment. It is essential to observe how this medication affects you before driving or operating machinery. Do not drive or operate machinery if you feel drowsy, dizzy, have blurred vision, or have difficulty concentrating. Be particularly cautious at the start of treatment, after a dose change, and when taking it with alcohol or tranquilizers.

3. How to take Palgesic retard

Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

Your doctor will adjust the dose based on the intensity of your pain and your personal sensitivity to pain. Generally, you should take the minimum effective dose to relieve pain.

The tablet can be divided into equal doses.

Adults

The recommended dose is 1 tablet every 12 hours. Do not recommend daily total doses exceeding 500 mg of tapentadol.

Your doctor may prescribe a different dose or a more suitable dosing regimen if necessary. If you think the effect of these tablets is too strong or too weak, consult your doctor or pharmacist.

Older patients

In older patients (over 65 years old), it is usually not necessary to adjust the dose. However, the elimination of tapentadol may be delayed and slower in certain patients of this age group. If this happens to you, your doctor may prescribe a different dosing regimen.

Liver and kidney diseases (hepatic and renal insufficiency)

Patients with severe liver problems should not take these tablets. If you have moderate liver problems, your doctor will prescribe a different dosing regimen. In case of mild liver problems, no dose adjustment is necessary.

Patients with severe kidney problems should not take these tablets. In case of mild or moderate kidney problems, no dose adjustment is necessary.

Use in children and adolescents

Tapentadol is not indicated in children and adolescents under 18 years old.

How and when to take tapentadol

Tapentadol should be taken orally.

Always take the tablets with a sufficient amount of liquid.

You can take the tablets whole or broken in half through the notch. Do not chew or crush them, as this could lead to an overdose because the active ingredient will be released in your body too quickly.

You can take them on an empty stomach or with meals.

The coating of the tablet may not be fully digested and may appear, apparently unchanged, in the stool. This should not worry you, as the active ingredient of the tablet will have already been absorbed by the body and what you see is only the empty coating.

Instructions for opening the blister pack

This medication is packaged in pre-cut, single-dose safety blisters that are child-resistant. You cannot push the tablet out of the blister. Please follow the following instructions for opening the blister pack:

1. Cut a dose along the pre-cut lines of the blister.

2. Locate the non-sealed area where the pre-cut lines intersect.

3. Pull the non-sealed area to separate the sheet.

For how long should tapentadol be taken

Do not take the tablets for longer than your doctor has indicated.

If you take more tapentadol than you should

After taking very high doses, you may experience some of the following effects:

  • very small pupils, vomiting, decreased blood pressure, rapid heart rate, dizziness, altered consciousness or coma (deep loss of consciousness), seizures, slow or shallow breathing to dangerous levels or respiratory arrest.

If any of these things happen, call a doctor immediately!

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20 indicating the medication and the amount used. It is recommended to bring the packaging and the medication leaflet to the healthcare professional.

If you forget to take tapentadol

If you forget to take a tablet, it is likely that you will feel pain again. Do not take a double dose to compensate for the missed doses, but continue taking the tablets as before.

If you interrupt the treatment with tapentadol

If you interrupt or stop taking the treatment too soon, it is likely that you will feel pain again. If you want to interrupt the treatment, consult your doctor before doing so.

Generally, patients do not experience any adverse effects after interrupting treatment, but in rare cases, people who have taken the tablets for a long time may feel unwell if they stop taking them suddenly.

The symptoms may be:

  • anxiety, runny eyes, nasal congestion, yawning, sweating, chills, muscle pain, and dilated pupils,
  • irritability, anxiety, back pain, joint pain, weakness, abdominal cramps, difficulty sleeping, nausea, loss of appetite, vomiting, diarrhea, and increased blood pressure, respiratory rate, or heart rate.

If you experience any of these symptoms after interrupting treatment, consult your doctor.

You should not stop taking this medication abruptly, unless your doctor tells you to. If your doctor wants you to stop taking these tablets, they will indicate how to do it, which may involve a gradual reduction in dose.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

4. Possible Adverse Effects

Like all medications, this medication may cause side effects, although not everyone will experience them.

Important side effects or symptoms to be aware of and what to do if you are affected by them:

This medication may cause allergic reactions. Symptoms may include wheezing (a whistling sound when breathing), difficulty breathing, inflammation of the eyelids, face, or lips, skin rash or itching, especially if it affects the entire body.

Another serious side effect consists of breathing more slowly or more weakly than normal. It occurs mainly in elderly patients or in weakened patients.

If you experience any of these important symptoms, consult your doctor immediately.

Other side effects that may occur:

Very common(may affect more than 1 in 10 people): nausea, constipation, dizziness, drowsiness, headache.

Common(may affect up to 1 in 10 people): decreased appetite, anxiety, depression, difficulty sleeping, nervousness, restlessness, attention disturbances, tremors, muscle tics, hot flashes, shortness of breath, vomiting, diarrhea, poor digestion, itching, increased sweating, skin eruptions, feeling of weakness, fatigue, feeling of change in body temperature, dryness of mucous membranes, accumulation of water in tissues (edema).

Uncommon(may affect up to 1 in 100 people): allergic reaction to medications (including hives, urticarial rash, and in severe cases difficulty breathing, decreased blood pressure, collapse, or shock), weight loss, disorientation, confusion, excitability (agitation), perception disturbances, sleep disturbances, euphoric mood, depression of consciousness level, memory deterioration, mental deterioration, fainting, sedation, balance disorders, difficulty speaking, numbness, abnormal skin sensations (e.g., tingling, itching), vision disturbances, rapid heartbeats, slow heartbeats, palpitations, decreased blood pressure, abdominal discomfort, hives, delayed urination, frequent urination, sexual dysfunction, withdrawal syndrome from medications (see section “If you interrupt treatment with tapentadol”), feeling of discomfort, irritability.

Rare(may affect up to 1 in 1,000 people): drug dependence, thought disturbances, seizures, feeling of impending fainting, coordination disturbances, slow or shallow breathing to dangerous levels (respiratory depression), gastric emptying disturbances, feeling of intoxication, feeling of relaxation.

Unknown frequency(cannot be estimated from available data): delirium.

In general, the possibility of having suicidal thoughts and behaviors increases in patients with chronic pain. Additionally, some medications for treating depression (affecting neurotransmitters in the brain) may increase this risk, especially at the beginning of treatment. Although tapentadol also affects neurotransmitters, through experience in patients it has not been proven to increase this risk.

Reporting of side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medications for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Conservation of Palgesic retard

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date that appears on the box and on the blister pack after CAD. The expiration date is the last day of the month indicated.

This medication does not require special storage conditions.

Medications should not be disposed of through drains or in the trash.Deposit containers and medications you no longer need at the SIGRE collection pointat the pharmacy.Ask your pharmacist how to dispose of containers and medications you no longer need. By doing so, you will help protect the environment.

6. Contents of the packaging and additional information

Composition of Palgesic retard

The active principleis tapentadol.

Palgesic retard 25 mg prolonged-release tablets EFG

Each prolonged-release tablet contains 25 mg of tapentadol (in the form of phosphate).

Palgesic retard 50 mg prolonged-release tablets EFG

Each prolonged-release tablet contains 50 mg of tapentadol (in the form of phosphate).

Palgesic retard 100 mg prolonged-release tablets EFG

Each prolonged-release tablet contains 100 mg of tapentadol (in the form of phosphate).

Palgesic retard 150 mg prolonged-release tablets EFG

Each prolonged-release tablet contains 150 mg of tapentadol (in the form of phosphate).

Palgesic retard 200 mg prolonged-release tablets EFG

Each prolonged-release tablet contains 200 mg of tapentadol (in the form of phosphate).

Palgesic retard 250 mg prolonged-release tablets EFG

Each prolonged-release tablet contains 250 mg of tapentadol (in the form of phosphate).

The othercomponents (excipients) are:

  • Tablet core:microcrystalline cellulose, hypromellose, anhydrous colloidal silica, magnesium stearate.
  • Tablet coating:hypromellose, glycerol, talc, microcrystalline cellulose, titanium dioxide (E 171),

iron oxide red (E172) (only for the 25, 100, 150, 200, and 250 mg doses), iron oxide yellow (E172) (only for the 25, 100, and 200 mg doses), iron oxide black (E172) (only for the 25, 100, 150, 200, and 250 mg doses).

Appearance of Palgesic retard and contents of the package

Palgesic retard 25 mg prolonged-release tablets EFG:film-coated tablets, brown in color, oblong, biconvex (5.7 mm x 12.2 mm), with a groove on both sides.

Palgesic retard 50 mg prolonged-release tablets EFG:film-coated tablets, white in color, oblong, biconvex (6.2 mm x 13.2 mm), with a groove on both sides.

Palgesic retard 100 mg prolonged-release tablets EFG:film-coated tablets, yellowish in color, oblong, biconvex (6.7 mm x 14.2 mm), with a groove on both sides.

Palgesic retard 150 mg prolonged-release tablets EFG:film-coated tablets, bright reddish in color, oblong, biconvex (7.2 mm x 15.2 mm), with a groove on both sides.

Palgesic retard 200 mg prolonged-release tablets EFG:film-coated tablets, yellow in color, oblong, biconvex (7.7 mm x 16.2 mm), with a groove on both sides.

Palgesic retard 250 mg prolonged-release tablets EFG:film-coated tablets, brownish reddish in color, oblong, biconvex (8.7 mm x 18.2 mm), with a groove on both sides.

Available in packs of 60 units, packaged in a pre-cut, unit-dose, aluminum-PVC/PE/PVDC blister pack, child-resistant.

Marketing authorization holder

Kern Pharma, S.L.

Venus, 72 - Pol. Ind.Colón II

08228 Terrassa – Barcelona

Spain

Responsible for manufacturing

Develco Pharma GmbH

Grienmatt 27

79650 Schopfheim

Germany

Last review date of this leaflet: August 2023

The detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) ( http://www.aemps.gob.es/)

About the medicine

Ile kosztuje Palgesic retard 50 mg comprimidos de liberaciÓn prolongada efg w Hiszpania ( 2025)?

Średnia cena Palgesic retard 50 mg comprimidos de liberaciÓn prolongada efg w wrzesień 2025 to około 22.01 €. Ceny mogą się różnić w zależności od regionu, apteki oraz wymogu recepty. Zawsze sprawdź aktualne informacje w lokalnej aptece.

Porozmawiaj z lekarzem online

Masz pytania o lek lub objawy? Lekarz online oceni Twój przypadek i, jeśli to potrzebne, wystawi e-receptę.

0.0(8)
Doctor

Dmytro Horobets

Medycyna rodzinna6 lat doświadczenia

Lek. Dmytro Horobets jest licencjonowanym lekarzem rodzinnym w Polsce, specjalizującym się w endokrynologii, diabetologii, leczeniu otyłości, gastroenterologii, pediatrii, chirurgii ogólnej oraz terapii bólu. Prowadzi konsultacje online dla dorosłych i dzieci, oferując spersonalizowane wsparcie medyczne w przypadku szerokiego zakresu chorób ostrych i przewlekłych.

Obszary specjalizacji obejmują:

  • Endokrynologia: cukrzyca typu 1 i 2, stan przedcukrzycowy, choroby tarczycy, zespół metaboliczny, zaburzenia hormonalne
  • Leczenie otyłości: indywidualne plany redukcji masy ciała, porady żywieniowe, ocena ryzyka zdrowotnego związanego z otyłością
  • Gastroenterologia: refluks żołądkowo-przełykowy (GERD), zapalenie żołądka, zespół jelita drażliwego (IBS), choroby wątroby i dróg żółciowych
  • Opieka pediatryczna: infekcje, objawy ze strony układu oddechowego, dolegliwości trawienne, monitorowanie rozwoju i wzrastania
  • Wsparcie chirurgiczne: konsultacje przed- i pooperacyjne, opieka nad ranami, rehabilitacja
  • Terapia bólu: ból przewlekły i ostry, bóle kręgosłupa, stawów, zespoły bólowe pourazowe
  • Zdrowie sercowo-naczyniowe: nadciśnienie, kontrola cholesterolu, ocena ryzyka chorób serca
  • Medycyna profilaktyczna: badania kontrolne, profilaktyczne, długoterminowe prowadzenie chorób przewlekłych
Lek. Horobets łączy praktykę opartą na dowodach z podejściem skoncentrowanym na pacjencie. Dokładnie analizuje historię choroby i objawy, zapewniając jasne wyjaśnienia i strukturalne plany leczenia dostosowane do indywidualnych potrzeb.

Niezależnie od tego, czy potrzebujesz wsparcia w kontroli cukrzycy, radzeniu sobie z otyłością, interpretacji wyników badań, czy opieki rodzinnej – dr Horobets zapewnia profesjonalną pomoc online, dostosowaną do Twoich celów zdrowotnych.

CameraUmów wizytę online
Więcej terminów
5.0(10)
Doctor

Taisiya Minorskaya

Pediatria12 lat doświadczenia

Lek. Taisiya Minorskaya jest pediatrą i lekarzem medycyny rodzinnej z Hiszpanii. Prowadzi konsultacje online dla dzieci, młodzieży i dorosłych, oferując kompleksową opiekę w zakresie nagłych objawów, chorób przewlekłych, profilaktyki i zdrowego stylu życia.

Wsparcie dla dzieci:

  • Infekcje ostre: kaszel, ból gardła, gorączka, wysypki.
  • Problemy ze snem, opóźnienia rozwojowe, wsparcie żywieniowe i emocjonalne.
  • Astma, alergie, atopowe zapalenie skóry i inne choroby przewlekłe.
  • Szczepienia rutynowe, profilaktyczne badania kontrolne, monitoring zdrowia.
  • Wsparcie dla rodziców: opieka, styl życia, adaptacja.
Wsparcie dla dorosłych:
  • Objawy ostre: infekcje, bóle, problemy z ciśnieniem, dolegliwości trawienne, zaburzenia snu.
  • Leczenie chorób przewlekłych: nadciśnienie, choroby tarczycy, zaburzenia metaboliczne.
  • Zdrowie psychiczne: lęk, przewlekłe zmęczenie, wahania nastroju.
  • Kontrola masy ciała i leczenie otyłości: ocena medyczna, indywidualny plan żywieniowy i aktywności, farmakoterapia w razie potrzeby.
  • Profilaktyka, badania przesiewowe, interpretacja wyników i dostosowanie leczenia.
Lek. Minorskaya łączy podejście oparte na dowodach naukowych z całościowym spojrzeniem na pacjenta – uwzględniając jego wiek, potrzeby i kontekst rodzinny. Dzięki podwójnej specjalizacji zapewnia długoterminowe wsparcie medyczne zarówno dzieciom, jak i dorosłym, pomagając poprawić jakość życia i utrzymać zdrowie na każdym etapie.
CameraUmów wizytę online
Więcej terminów
5.0(21)
Doctor

Ekaterina Agapova

Neurologia8 lat doświadczenia

Lek. Ekaterina Agapova jest neurologiem specjalizującym się w diagnostyce i leczeniu chorób układu nerwowego oraz przewlekłego bólu. Prowadzi konsultacje online dla dorosłych, łącząc medycynę opartą na faktach ze spersonalizowanym podejściem.

Zakres konsultacji obejmuje m.in.:

  • Bóle głowy i migreny, w tym napięciowe i klasterowe.
  • Bóle karku i pleców – ostre i przewlekłe.
  • Zespoły bólu przewlekłego: fibromialgia, ból neuropatyczny, ból pourazowy.
  • Mononeuropatie: zespół cieśni nadgarstka, neuralgia nerwu trójdzielnego, porażenie nerwu twarzowego.
  • Polineuropatie: cukrzycowe, toksyczne i inne.
  • Stwardnienie rozsiane – diagnostyka, monitorowanie, długoterminowe wsparcie.
  • Zawroty głowy i zaburzenia koordynacji.
  • Zaburzenia snu: bezsenność, nadmierna senność dzienna, sen przerywany.
  • Lęk, depresja i zaburzenia związane ze stresem.
Lek. Agapova pomaga pacjentom radzić sobie z objawami neurologicznymi, takimi jak ból, drętwienie, osłabienie, problemy ze snem czy obniżony nastrój. Jej konsultacje koncentrują się na trafnej diagnostyce, jasnym wyjaśnieniu wyników oraz opracowaniu indywidualnego planu leczenia.

Jeśli zmagasz się z przewlekłym bólem, migrenami, neuropatią lub problemami ze snem, lek. Agapova oferuje profesjonalne wsparcie, aby poprawić Twoje samopoczucie.

CameraUmów wizytę online
Więcej terminów
5.0(37)
Doctor

Yevgen Yakovenko

Chirurgia ogólna11 lat doświadczenia

Lek. Yevgen Yakovenko jest licencjonowanym chirurgiem i lekarzem medycyny ogólnej w Hiszpanii i Niemczech. Specjalizuje się w chirurgii ogólnej, dziecięcej i onkologicznej, a także w internie i leczeniu bólu. Prowadzi konsultacje online dla dorosłych i dzieci, łącząc precyzję chirurgiczną z kompleksowym wsparciem terapeutycznym. Konsultuje pacjentów w językach: ukraińskim, rosyjskim, angielskim i hiszpańskim.

Zakres konsultacji obejmuje:

  • Bóle ostre i przewlekłe: bóle głowy, mięśni, stawów, kręgosłupa, brzucha, bóle pooperacyjne. Identyfikacja przyczyn, dobór terapii, plan opieki.
  • Medycyna wewnętrzna: serce, płuca, układ pokarmowy, układ moczowy. Leczenie chorób przewlekłych, kontrola objawów, drugie opinie.
  • Opieka przed- i pooperacyjna: ocena ryzyka, wsparcie w podejmowaniu decyzji, kontrola po zabiegu, strategie rehabilitacyjne.
  • Chirurgia ogólna i dziecięca: przepukliny, zapalenie wyrostka robaczkowego, wady wrodzone, zabiegi planowe i pilne.
  • Urazy i kontuzje: stłuczenia, złamania, skręcenia, uszkodzenia tkanek miękkich, leczenie ran, opatrunki, skierowania do leczenia stacjonarnego.
  • Chirurgia onkologiczna: weryfikacja diagnozy, planowanie terapii, długoterminowa opieka pooperacyjna.
  • Leczenie otyłości i kontrola masy ciała: medyczne podejście do redukcji wagi, ocena chorób towarzyszących, indywidualny plan (dieta, aktywność fizyczna, farmakoterapia), monitorowanie postępów.
  • Interpretacja badań obrazowych: analiza wyników USG, TK, MRI i RTG, planowanie zabiegów chirurgicznych na podstawie danych obrazowych.
  • Drugie opinie i nawigacja medyczna: wyjaśnianie diagnoz, przegląd planów leczenia, pomoc w wyborze najlepszego postępowania.
Doświadczenie i kwalifikacje:
  • Ponad 12 lat praktyki klinicznej w szpitalach uniwersyteckich w Niemczech i Hiszpanii
  • Wykształcenie międzynarodowe: Ukraina – Niemcy – Hiszpania
  • Członek Niemieckiego Towarzystwa Chirurgów (BDC)
  • Certyfikaty z diagnostyki radiologicznej i chirurgii robotycznej
  • Aktywny uczestnik międzynarodowych konferencji i badań naukowych
Lek. Yakovenko tłumaczy złożone zagadnienia w prosty i zrozumiały sposób. Współpracuje z pacjentami, aby analizować problemy zdrowotne i podejmować decyzje oparte na dowodach naukowych. Jego podejście łączy wysoką jakość kliniczną, rzetelność naukową i indywidualne podejście do każdego pacjenta.

Jeśli nie jesteś pewien diagnozy, przygotowujesz się do operacji lub chcesz omówić wyniki badań – Lek. Yakovenko pomoże Ci ocenić opcje i podjąć świadomą decyzję.

CameraUmów wizytę online
Więcej terminów
Zobacz wszystkich lekarzy

Zapisz się na aktualizacje

Otrzymuj informacje o nowych usługach online, zmianach i ofertach dostępnych na Oladoctor w Europie.

Zapisz się
Śledź nas w mediach społecznościowych
FacebookInstagram
Logo
Oladoctor
Znajdź lekarza
Lekarze według specjalizacji
Usługi
Choose language
© 2025 Oladoctor. All rights reserved.
VisaMastercardStripe